female urology

Despite warnings, mesh use for prolapse on the riseUse of mesh in the treatment of pelvic organ prolapse is increasing, despite FDA warnings about its risks.
FDA OKs urinary prosthesis, lymphatic mapping agentIn separate actions, the FDA allowed the marketing of a urinary prosthesis for women and approved a supplemental new drug application for a lymphatic mapping agent.
AUA 2014: Studies shine light on new PCa tests, TRT safetyIn our “Best of AUA” report, Urology Times’ editors and writers present the AUA annual meeting’s take-home messages in 15 therapeutic areas.
Best of AUA 2014: Female Urology/Incontinence/UrodynamicsAdonis K. Hijaz, MD, presents the take home messages on female urology/incontinence/urodynamics from the AUA annual meeting in Orlando, FL, including studies on mesh outcomes and the overactive bladder treatment mirabegron (Myrbetriq).
Female urology research examines sling surgery, robotic approaches, meshSling surgery, robotic approaches to sacrocolpopexy and pelvic organ prolapse, and mesh are among the key studies in the area of female urology to watch for at the 2014 AUA annual meeting.
Best of AUA 2013: Female Urology/Incontinence/UrodynamicsPriya Padmanabhan, MD, MPH, presents the take home messages on female urology/incontinence/urodynamics from the AUA annual meeting in San Diego.
Slings, botulinum toxin among key female urology topicsIn the area of female urology, look for key studies at the AUA annual meeting involving sling surgery, onabotulinumtoxinA (Botox) injections, and reoperation after pelvic organ prolapse surgery with mesh.
  • 1
  • 2